grant

Mechanisms and Consequences of Mycobacterial N-terminal Protein Acetylation

Organization UNIVERSITY OF NOTRE DAMELocation NOTRE DAME, UNITED STATESPosted 10 May 2013Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY2024AcetylationAcetyltransferaseAffectAmino AcidsAnimalsAntibiotic AgentsAntibiotic DrugsAntibiotic ResistanceAntibioticsAreaAssayBacteriaBacterial Gene ProductsBacterial Gene ProteinsBacterial InfectionsBacterial ProteinsBacteriologyBindingBioassayBiochemicalBiological AssayCancersCarbonChargeChemistryCholesterolChronicClosure by LigationDataDegenerative Neurologic DisordersDiagnosisDiseaseDisorderELF3ELF3 geneEPR-1ERT geneERT proteinESE-1ESXEnzyme GeneEnzymesEpidemicEventFoundationsFundingFutureGeneralized GrowthGeneticGenus MycobacteriumGrowthHalf-LifeHumanIn VitroIndividualInfectionIntermediary MetabolismKnowledgeL-LysineLabelLigationLinkLipidsLysineM marinumM tbM tuberculosisM tuberculosis infectionM. marinumM. tbM. tb infectionM. tuberculosisM. tuberculosis infectionM.tb infectionM.tuberculosis infectionMTB infectionMacrophageMalignant NeoplasmsMalignant TumorMetabolic ProcessesMetabolismMethodsMiscellaneous AntibioticMissionModelingModern ManModificationMolecularMolecular InteractionMycobacteriumMycobacterium marinumMycobacterium tuberculosisMycobacterium tuberculosis (MTB) infectionMycobacterium tuberculosis infectionN-terminalNH2-terminalNational Institutes of HealthNervous System Degenerative DiseasesNeural Degenerative DiseasesNeural degenerative DisordersNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsOrganismParasitic infectionPathogenesisPathogenicityPathogenicity FactorsPathway interactionsPeptidesPhasePhenotypePost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingPreventionProcessProductivityProtein AcetylationProtein ModificationProteinsProteomicsProtocolProtocols documentationPublic HealthPublishingRegulationResearchResistance to antibioticsResistant to antibioticsSourceSubstrate SpecificitySystemTB infectionTB therapyTB treatmentTestingTissue GrowthTransfer RNATriplet Codon-Amino Acid AdaptorTuberculosisUnited States National Institutes of HealthVirulenceVirulence Factorsamino groupaminoacidantibiotic drug resistanceantibiotic resistantbacteria infectionbacterial diseasechronic infectiondegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedisseminated TBdisseminated tuberculosisgene manipulationgenetic manipulationgenetically manipulategenetically perturbhuman pathogeninfection due to Mycobacterium tuberculosisinnovateinnovationinnovativeliving systemmalignancymtbmycobacterialneoplasm/cancerneurodegenerative illnessnew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel therapeutic targetnovel therapy targetontogenyparasite infectionpathogenpathwaypersistent infectionprotein functionsmall moleculetRNAtherapeutic agent developmenttherapeutic developmenttherapeutic targettooltransfer Ribonucleic acidstreat M. tuberculosistreat Mtbtreat Mycobacterium tuberculosistreat tbtreat tuberculosistuberculosis infectiontuberculosis therapytuberculosis treatmenttuberculous spondyloarthropathyvaccine development
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY:
N-terminal (Nt) acetylation is an understudied aspect of bacteriology. Nt-acetylation is the addition of an acetyl

group to the amino group on the α-carbon of the first amino acid of a protein. The fundamental mechanisms

promoting and regulating Nt-acetylation, and the consequences of this modification in bacteria remain undefined.

The objective of this renewal application is to define the fundamental mechanisms underlying Nt-acetylation in

mycobacteria. The central hypothesis is that protein Nt-acetylation is a dynamic, regulated process that directly

impacts mycobacterial virulence. The central hypothesis will be tested by following these specific aims: 1) Define

the enzymes promoting Nt-acetylation in mycobacteria. 2) Establish the mechanisms and consequences of vir-

ulence factor Nt-acetylation in mycobacteria. 3) Determine the link between Nt-acetylation and mycobacterial

metabolism. Under the first aim, the applicant proposes to use enrichment strategies combined with quantitative

proteomics to determine the function and substrate specificity of conserved mycobacterial NATs. Under the sec-

ond aim, in vitro biochemical assays will be combined with targeted and quantitative proteomics to identify the

NATs that modify essential mycobacterial virulence factors. Genetic and molecular approaches will be used to

define functional relationships between predicted NATs in mycobacteria. Under the third aim, the applicant will

combine enrichment and proteomics approaches to investigate differential Nt-acetylation following growth of

mycobacteria on host-relevant carbon sources. The applicant will use proximity-dependent labeling to identify

potential regulators of NAT activity. The successful completion of this proposal will contribute a fundamental

understanding of the mechanisms promoting Nt-acetylation and establish a link between NATs, Nt-acetylation

and essential mycobacterial virulence pathways. These contributions will be significant because they will ad-

vance our understanding of an understudied protein modification important for mycobacterial virulence, which

may be applicable to other bacterial species. The topic of this proposal is conceptually innovative because Nt

acetylation is an under-investigated protein modification in both areas of tuberculosis research and bacteriology.

Furthermore, studying the regulation of Nt-acetylation by metabolism to identify Nt-acetylation events essential

for mycobacterial virulence is an innovative idea. The proposal is technically innovative because the applicant

combines biochemical screens, enrichment protocols with bioanalytical chemistry, and expertise in molecular

and genetic manipulation of pathogenic mycobacteria. The applicant leverages both M. tuberculosis and M.

marinum strains to optimize productivity. These studies in bacteria will lay a foundation for focused and informed

studies in animal virulence models in the future. By rigorously studying the mechanisms and regulation of Nt-

acetylation in mycobacteria, the applicant may establish new therapeutic targets for treating mycobacterial dis-

ease.

Grant Number: 5R01AI106872-10
NIH Institute/Center: NIH

Principal Investigator: Patricia Champion

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →